ERS声明:儿童间质性肺疾病的过渡期管理
儿童间质性肺疾病(chILD)与成人ILD表现及预后不同,部分可缓解但需持续随访。欧洲呼吸学会(ERS)发布声明,综述chILD向成人医疗过渡的文献与现状,指出目前缺乏足够证据,尚不能给出循证推荐。
要点
- chILD患者无论病情持续或缓解,均应保障从儿科到成人医疗的主动过渡过程。
- 现有过渡体系在囊性纤维化等病中成熟,但chILD过渡缺乏已发表证据。
- 该ERS声明总结现有知识,尚不能提供循证临床推荐。
核心结论
- 应为每位chILD患者保障从儿科到成人医疗的主动过渡过程。
- 现有文献不足以支持chILD过渡体系的循证推荐。
研究设计与样本
- 欧洲呼吸学会(ERS)声明,基于文献综述与现有实践总结。
主要发现
- chILD常在幼年诊断,影响发育中的肺,表现和预后与成人ILD不同。
- 许多chILD可明显缓解,对治疗反应和预后优于成人ILD。
- 部分患儿成年时疾病轻微活动或临床缓解,仍需持续随访。
- 囊性纤维化、糖尿病等慢性病过渡体系成熟,但chILD过渡缺乏已发表证据。
- 当前成人ILD与chILD分类缺乏协调,影响过渡管理。
临床怎么用
- 对每位chILD患者应主动规划儿科至成人医疗的过渡。
- 过渡期需持续随访,即使无症状或完全缓解也不应中断。
局限性
- 未能找到关于chILD过渡体系的足够已发表证据。
- 本声明尚不能提供循证临床推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interstitial lung diseases (ILD) are a heterogeneous group of rare diffuse diseases affecting the lung parenchyma in children and adults. Childhood interstitial lung diseases (chILD) are often diagnosed at very young age, affect the developing lung, and can have different presentations and prognosis compared to adult forms of these diseases. In addition, chILD in many cases may apparently remit, and have a better response to therapy and better prognosis than adult ILD. Many affected children will reach adulthood with minimal activity or clinical remission of the disease. They need continuing care and follow-up from childhood to adulthood if the disease persists and progresses over time, but also if they are asymptomatic and in full remission. Therefore, for every chILD patient an active transition process from paediatric to adult care should be guaranteed. This European Respiratory Society (ERS) statement provides a review of the literature and current practice concerning transition of care in chILD. It draws on work in existing transition care programmes in other chronic respiratory diseases, disease-overarching transition-of-care programmes, evidence on the impact of these programmes on clinical outcomes, current evidence regarding long-term remission of chILD as well as the lack of harmonisation between the current adult ILD and chILD classifications impacting on transition of care. While the transition system is well established in several chronic diseases, such as cystic fibrosis or diabetes mellitus, we could not find sufficient published evidence on transition systems in chILD. This statement summarises current knowledge, but cannot yet provide evidence-based recommendations for clinical practice.
引用
- Pohunek P, Manali E, Vijverberg S, et al. ERS statement on transition of care in childhood interstitial lung diseases. Eur Respir J. 2024. PMID: 38843911. doi:10.1183/13993003.02160-2023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。